[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Roche Holding Ltd ADR (RHHBY)

Roche Holding Ltd ADR (RHHBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 337,893,376
  • Shares Outstanding, K 6,370,538
  • Annual Sales, $ 76,471 M
  • Annual Income, $ 15,546 M
  • EBIT $ 0 M
  • EBITDA $ 26,387 M
  • 60-Month Beta 0.50
  • Price/Sales 4.19
  • Price/Cash Flow 13.98
  • Price/Book 7.01
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 01/29/26
  • Annual Dividend & Yield (Fwd) 0.97 (1.93%)
  • Most Recent Dividend 0.972 on 03/13/26
  • Sector Medical
  • INDUSTRY GROUPING Large Cap Pharma

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.8300 +8.62%
on 06/03/26
53.4967 -0.85%
on 07/02/26
+3.9700 (+8.09%)
since 06/02/26
3-Month
48.1000 +10.27%
on 06/02/26
53.5400 -0.93%
on 05/22/26
+3.1900 (+6.40%)
since 04/02/26
52-Week
37.5100 +41.40%
on 08/11/25
60.8500 -12.83%
on 02/24/26
+11.8900 (+28.89%)
since 07/02/25

Most Recent Stories

More News
1 of the Most Interesting AI Stocks in the Market Isn’t a Tech Company

Recursion Pharmaceuticals is trying to prove that AI’s next big winner can also come from biotech, and not just from the tech sector.

RXRX : 3.80 (+3.54%)
RHHBY : 53.0400 (+5.41%)
SNY : 43.16 (+3.68%)
Nuvalent Stock Hits All-Time High Following GSK's Buyout Offer

Nuvalent shares soar as GSK announces a $10.6 billion buyout deal. But is it too late already to invest in NUVL stock?

NUVL : 123.73 (+0.11%)
RHHBY : 53.0400 (+5.41%)
GSK : 53.66 (+4.60%)
PFE : 24.32 (+1.84%)
Tango Therapeutics (TNGX) Stock Soars on Pancreatic Cancer Trial Results

Tango Therapeutics shares rallied on Monday after recording impressive results for its pancreatic cancer drug. Here’s how you should play TNGX stock at current levels.

IDYA : 37.65 (+4.09%)
JNJ : 263.04 (+3.57%)
INCY : 116.86 (+2.68%)
TNGX : 29.46 (+2.54%)
RHHBY : 53.0400 (+5.41%)
3G Capital Exits Microsoft Stock in Major Portfolio Shift. MSFT Is Still One of the Best AI Plays Now.

3G Capital dumped Microsoft stock and piled into semiconductor names. Here's what the move says about AI investing right now, and whether MSFT remains a buy.

MSFT : 390.49 (+1.62%)
BABA : 96.14 (-1.89%)
BAYRY : 15.1850 (+9.64%)
JNJ : 263.04 (+3.57%)
MBGAF : 51.5000 (+2.94%)
ACN : 137.35 (+4.74%)
RHHBY : 53.0400 (+5.41%)
3 ETFs to Avoid as Oil Shock Hits Markets

With oil prices soaring near $100 per barrel, certain sectors are feeling more pain than others. Here are three ETFs to avoid amid oil's market roil.

LVMUY : 113.8700 (+4.04%)
TRIP : 14.29 (+3.93%)
TSLA : 393.45 (-7.49%)
SAP : 162.59 (+2.16%)
XLY : 117.12 (-0.82%)
JETS : 33.20 (-0.09%)
EXPE : 268.69 (+1.57%)
NVS : 159.90 (+3.74%)
VGK : 89.35 (+1.80%)
RHHBY : 53.0400 (+5.41%)
AMZN : 242.67 (+0.40%)
Looking to ‘Sell America’ Amid Fed Drama? Here’s 1 ETF to Buy.

'Sell America' fear is rising again, and this non-U.S. ETF could be a wise buy to stay diversified and invested globally while U.S. policy risks swirl.

BLK : 995.73 (+1.57%)
BABA : 96.14 (-1.89%)
DXY00 : 100.857s (unch)
SIH26 : 69.545s (+2.77%)
GCG26 : 5,206.4s (+0.98%)
NVS : 159.90 (+3.74%)
RHHBY : 53.0400 (+5.41%)
HSBC : 96.78 (+1.01%)
TSM : 434.16 (-2.27%)
ASML : 1,769.32 (-4.00%)
$DXY : 100.85 (-0.12%)
AZN : 195.15 (+6.14%)
Olema Pharmaceuticals Has Nearly Tripled on Cancer Drug Hopes. How Should You Play OLMA Stock Here?

Olema stock soared Tuesday after Roche reported strong clinical results for its breast cancer drug. An Oppenheimer analyst sees significant further upside in OLMA shares to $45.

OLMA : 12.64 (+4.64%)
RHHBY : 53.0400 (+5.41%)
Roche Holding AG (RHHVF) Gets a Buy from DZ BANK AG

DZ BANK AG analyst Elmar Kraus maintained a Buy rating on Roche Holding AG today. The company’s shares closed yesterday at $351.28.Elevate Your Investing Strategy: Take advantage of TipRanks Premium...

RHHVF : 410.8000 (-1.39%)
RHHBY : 53.0400 (+5.41%)
CHRO : 1.3500 (+7.14%)
UBS Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)

In a report released today, Matthew Weston from UBS maintained a Buy rating on Roche Holding AG, with a price target of CHF314.00. The company’s shares closed last Friday at $357.00.Elevate Your Investing...

RHHVF : 410.8000 (-1.39%)
RHHBY : 53.0400 (+5.41%)
CHRO : 1.3500 (+7.14%)
J.P. Morgan Sticks to Their Sell Rating for Roche Holding AG (RHHVF)

In a report released today, Richard Vosser from J.P. Morgan maintained a Sell rating on Roche Holding AG, with a price target of CHF230.00. The company’s shares closed last Friday at $357.00.Elevate...

RHHVF : 410.8000 (-1.39%)
RHHBY : 53.0400 (+5.41%)
CHRO : 1.3500 (+7.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Basel, Switzerland-based Roche Holding Ltd. is a leading health care company focused on developing and commercializing innovative diagnostic and therapeutic products and services, which enable early detection and prevention of diseases as well as their treatment and monitoring. The company conducts its...

See More

Key Turning Points

3rd Resistance Point 54.8545
2nd Resistance Point 54.1756
1st Resistance Point 53.6078
Last Price 53.0400
1st Support Level 52.3611
2nd Support Level 51.6822
3rd Support Level 51.1144

See More

52-Week High 60.8500
Last Price 53.0400
Fibonacci 61.8% 51.9341
Fibonacci 50% 49.1800
Fibonacci 38.2% 46.4259
52-Week Low 37.5100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.